mTOR pathway in cutaneous T cell lymphoma

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 45,962 followers.

RT @FrontImmunol: New Research: ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma: Bac…

23 Dec 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma: Bac…

22 Dec 2023

Reply Repost Favourite

ATF5 promueve la supervivencia de células T malignas a través de la vía PI3K/AKT/mTOR en el linfoma cutáneo de células T. https://t.co/VKr8ybmwy5

22 Dec 2023

Reply Repost Favourite

New Research: ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma: Backgrounds Cutaneous T cell lymphoma (CTCL) is a non-Hodgkin lymphoma characterized by skin infiltration of malignant T… https://t.co/xs

22 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.